
Diabetic Neuropathy
Non-Pharmacological Management
Foot Care:
Wear well-fitting footwear
Perform daily self-examination of feet for wounds, blisters, or skin changes
Regular podiatry reviews
Refer to high-risk foot clinic if necessary
Refer to vascular surgeon for advanced complications
Optimise Systemic Health:
Achieve good glycaemic control
Manage cardiovascular risk factors (e.g., smoking cessation, blood pressure, lipids)
____________________________________
Pharmacological Management
1st-line Meds for Painful Neuropathy may either be:
Amitriptyline: 25 mg at night (titrated up to 150 mg nocte if tolerated)
Duloxetine: 60 mg daily (max 120 mg/day)
Pregabalin: 75 mg twice daily (titrate up to 300 mg bd)
Gabapentin: Start at 300 mg daily (max 1200 mg tid)
Adjuncts:
Topical capsaicin cream (if oral medications are not tolerated)
Note:
Titrate medications gradually to minimise SEs. Lower starting doses for elderly patients.
Topical nitrate spray (not on eTG but on racgp T2DM handbook)
____________________________________
Important Considerations
Screen for other causes of neuropathy (e.g., vitamin B12 deficiency, hypothyroidism)
Patients with loss of protective sensation (e.g., insensate neuropathy) are at high risk for foot ulcers and Charcot arthropathy
Regular foot assessments can prevent complications
Differentials for general and unilateral neuropathy
____________________________________
Differentials for general neuropathy
Diabetic neuropathy
Prolonged excessive alcohol use
Peripheral arterial disease
B12 deficiency
Hypothyroidism
Chronic kidney disease (peripheral oedema, change in urinary frequency)
Multiple myeloma
Idiopathic (25%)
Restless legs syndrome (strong urge to move legs)
Raynauds phenomenon
____________________________________
Differentials for unilateral neuropathy
L5/S1 nerve root compression (shooting pain from the back)
Chronic regional pain syndrome (recent trauma to the limb)
Mortons neuroma (worse with tight shoes)
Tarsal tunnel syndrome (PT nerve (medial))
____________________________________
Hallmark and Atypical Symptoms
Classic symptoms:
Numbness, tingling, or burning pain starting in the toes and progressing proximally (stocking-glove distribution)
Symmetrical and slow progression
Sensory loss that can coexist with pain (e.g., "painful insensate foot")
Atypical features:
Sudden or asymmetrical onset (e.g., diabetic amyotrophy or mononeuropathies)
Involvement of proximal muscles, such as pelvic or thigh girdle weakness (diabetic radiculoplexus neuropathy)
____________________________________
History
Typical symptoms:
Burning, aching pain and paraesthesia
Numbness or reduced sensation
Difficulty with balance, especially in the dark
Assess risk factors:
Poor glycaemic control
History of smoking, hypertension, or dyslipidaemia (risk factors for peripheral arterial disease)
Past foot ulcers or Charcot foot
____________________________________
Features of Examination for Peripheral Neuropathy
Neurological assessment:
Loss of protective sensation (e.g., absent 10 g monofilament response)
Reduced vibration perception (e.g., using a 128 Hz tuning fork)
Reduced ankle reflexes
Loss of pinprick or temperature sensation
MSK assessment:
Deformities such as claw toes, prominent metatarsal heads, or collapsed arches (Charcot foot features)
Other findings:
Signs of neuropathic ulceration or infection
Reduced peripheral pulses (if concomitant peripheral arterial disease is present)
____________________________________
Notes
Screening:
Routine annual screening is essential, even in asymptomatic patients, as neuropathy increases the risk of foot ulcers and amputations.
Prevention and Management:
Optimise glycaemic control to slow progression but note that established neuropathy is irreversible.
Address risk factors (e.g., smoking cessation, blood pressure, and lipid management).
Pain management options include amitriptyline, duloxetine, gabapentin, or pregabalin, titrated to response
Bookmark Failed!
Bookmark Saved!